IRIDEX CORP — Form SCHEDULE 13D/A
Filed July 13, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Novel Inspiration International Co., Ltd. and Xinpo Venture Capital Co., Ltd. executed an Amended and Restated Joint Filing Agreement on July 10, 2026, to file a Schedule 13D on behalf of both parties concerning IRIDEX Corporation common stock. The agreement establishes joint filing procedures and allocates responsibility for accuracy of information to each party. The filing itself does not disclose their current stake, voting arrangements, or the reason for the amendment.
Why this rating
Administrative amendment to joint filing protocol; no transaction, stake size, or control change disclosed. Routine procedural filing relative to $14.2M market cap.
See more from July 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.